Managing Intellectual Property

EU court adviser urges limits to bio-patent protection

09 March 2010

Emma Barraclough, London

A senior legal adviser to Europe’s highest court says that protection for patents over a DNA sequence should be limited to situations where the genetic information is performing the functions described in the patent

In his opinion in a dispute between Monsanto and a group of Argentine soya growers, Advocate General Mengozzi advised the Court to rule that patented DNA can only be protected as a chemical substance where it performs the function for which it is patented.

This is the first case where the Court of justice has been asked to interpret the scope of EU legislation on the protection of biotechnological inventions.

The dispute began when agrichemical company Monsanto asked a Dutch court to bock imports of soy meal into...



Only subscribers have complete access to Managing IP Magazine, log in or subscribe now.

Alternatively take a free trial, giving you 48-hour access to Managing IP Magazine (some articles and surveys may be excluded).

Subscribe Now

This article is available to subscribers. Please click subscribe to read the rest of the article.

Subscribe

Take a free trial

Please take a free 48-hour trial to gain limited access. Some articles and surveys may be excluded.

Take a free trial


INTA Daily News 2012

Read this year's INTA Daily News - published daily by Managing IP direct from the 134th INTA Annual Meeting in Washington DC

null null null
null null

May 2012

Do you want to be famous?

Famous, well-known, notorious, reputed: everyone wants enhanced protection for their trade marks. But should they, and what does it mean if it is? Emma Barraclough explains



Most read articles

Poll

Will the new post grant and inter partes review proceedings result in more litigators practising pro hac vice before the USPTO?







Supplements